Provided by Tiger Trade Technology Pte. Ltd.

PHARMARON

31.820
+1.7605.85%
Volume:8.33M
Turnover:260.94M
Market Cap:58.39B
PE:33.88
High:31.860
Open:29.720
Low:29.720
Close:30.060
52wk High:34.860
52wk Low:14.289
Shares:1.84B
HK Float Shares:358.00M
Volume Ratio:2.28
T/O Rate:2.33%
Dividend:0.23
Dividend Rate:0.73%
EPS(LYR):0.939
ROE:10.11%
ROA:4.87%
PB:3.06
PE(LYR):33.88
PS:3.28

Loading ...

Goldman Sachs: Asian CDMOs Enter a Structural Growth Cycle, with Peptides, ADCs, Oligonucleotides, and AIDD as New Engines

Stock News
·
Sep 30

Movement Alert|PHARMARON Rises 3.33% in Regular Trading, Pharma 15th Five-Year Plan Boosts CXO Sector Amid Strong Interim Results

Market Focus
·
Sep 30

Movement Alert|PHARMARON Rises 3.46% in Regular Trading, CXO Sector Rallies on Policy Tailwinds and Strong H1 Earnings

Market Focus
·
Sep 29

Zhitong AH Statistics: September 25 Market Overview

Stock News
·
Sep 25

JPMorgan Trims Stake in Pharmaron by About 1.12 Million Shares at Roughly HK$30.37 Each

Stock News
·
Sep 24

PHARMARON: BNP Paribas SA Acquires Shares, Long Position Rises to 5.31%

HK Disclosure
·
Sep 24

Pharmaron Releases 2026 Interim Report Online and Opens Printed Copy Requests

Bulletin Express
·
Sep 23

Movement Alert|PHARMARON Rises 4.16% in Regular Trading, CRO Sector Strength Continues as Multiple Investment Banks Raise Target Prices

Market Focus
·
Sep 23

Movement Alert|PHARMARON Rises 3.15% in Regular Trading, CRO Sector Momentum Extends on AI Pharma Catalyst and Policy Tailwinds

Market Focus
·
Sep 22

Movement Alert|PHARMARON Rises 3.25% in Regular Trading, CRO Sector Rallies on AI Pharma Catalyst and Policy Tailwinds

Market Focus
·
Sep 21

Movement Alert|PHARMARON Rises 3.61% in Regular Trading, CRO Sector Broadly Strengthens as AI Drug Discovery Catalyst Persists

Market Focus
·
Sep 18

PHARMARON: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 15.8%

HK Disclosure
·
Sep 17

PHARMARON: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 17.16%

HK Disclosure
·
Sep 16

Movement Alert|PHARMARON Rises 3.26% in Regular Trading, CRO Sector Stays Strong as Multiple Banks Raise Target Prices

Market Focus
·
Sep 16

Movement Alert|PHARMARON Rises 5.52% in Regular Trading, CRO Sector Rallies on Strong Mid-Year Earnings and Upgraded Guidance

Market Focus
·
Sep 14

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

Stock News
·
Sep 14

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Stock News
·
Sep 14

Movement Alert|PHARMARON Falls 3.39% in Regular Trading, Life Sciences Sector Under Broad Selling Pressure

Market Focus
·
Sep 11

Pharmaron Updates Articles of Association, Enhances Governance Framework and Dividend Policy

Bulletin Express
·
Sep 10

Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D

Stock News
·
Sep 08